- Home
- EJH vs VRAX Comparison
EJH vs VRAX Comparison
Compare EJH & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EJH
- VRAX
- Stock Information
- Founded
- EJH 2018
- VRAX 2013
- Country
- EJH China
- VRAX United Kingdom
- Employees
- EJH N/A
- VRAX N/A
- Industry
- EJH Other Consumer Services
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EJH Consumer Discretionary
- VRAX Health Care
- Exchange
- EJH Nasdaq
- VRAX Nasdaq
- Market Cap
- EJH 17.0M
- VRAX 2.8M
- IPO Year
- EJH 2021
- VRAX 2022
- Fundamental
- Price
- EJH $0.81
- VRAX $0.41
- Analyst Decision
- EJH
- VRAX Strong Buy
- Analyst Count
- EJH 0
- VRAX 1
- Target Price
- EJH N/A
- VRAX $3.00
- AVG Volume (30 Days)
- EJH 155.1K
- VRAX 151.2K
- Earning Date
- EJH 10-31-2025
- VRAX 01-01-0001
- Dividend Yield
- EJH N/A
- VRAX N/A
- EPS Growth
- EJH N/A
- VRAX N/A
- EPS
- EJH N/A
- VRAX N/A
- Revenue
- EJH $49,402,956.00
- VRAX $6,331.00
- Revenue This Year
- EJH N/A
- VRAX $217,274.83
- Revenue Next Year
- EJH N/A
- VRAX N/A
- P/E Ratio
- EJH N/A
- VRAX N/A
- Revenue Growth
- EJH N/A
- VRAX N/A
- 52 Week Low
- EJH $0.74
- VRAX $0.35
- 52 Week High
- EJH $64.00
- VRAX $3.20
- Technical
- Relative Strength Index (RSI)
- EJH 40.72
- VRAX 31.67
- Support Level
- EJH $0.77
- VRAX $0.35
- Resistance Level
- EJH $0.90
- VRAX $0.46
- Average True Range (ATR)
- EJH 0.11
- VRAX 0.04
- MACD
- EJH -0.01
- VRAX -0.00
- Stochastic Oscillator
- EJH 25.00
- VRAX 28.56
About EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).